EuroIntervention PCRonline - Connecting with the community

coronary artery disease

184 articles

A randomised comparison of biodegradable polymer- and permanent polymer-coated platinum-chromium everolimus-eluting coronary stents in China: the EVOLVE China study

EuroIntervention 2017;13:1210-1217 published online July 2017

Published in Volume 13 Number 10, November 2017

Qualitative and quantitative evaluation of dynamic changes in non-culprit coronary atherosclerotic lesion morphology. A longitudinal OCT study.

EuroIntervention 2017; just accepted article published in November 2017

Characteristics and outcome of patients with complex coronary lesions treated with bioresorbable scaffolds Three years follow-up in a cohort of consecutive patients

EuroIntervention 2017; just accepted article published in October 2017

The European Collaborative Project on Inflammation and Vascular Wall Remodeling in Atherosclerosis - Intravascular Ultrasound (ATHEROREMO-IVUS) Study

EuroIntervention 2017; just accepted article published in September 2017

Final five-year clinical outcomes in the EVOLVE trial: A randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent

EuroIntervention 2017; just accepted article published in September 2017

Physiological assessment of left main coronary artery disease

EuroIntervention 2017;13:820-827 published online June 2017

Published in Volume 13 Number 7, September 2017

State of the art: non-invasive imaging in ischaemic heart disease

EuroIntervention 2017;13:654-665

Published in Volume 13 Number 6, August 2017

The impact of microvascular resistance on the discordance between anatomical and functional evaluations of intermediate coronary disease

EuroIntervention 2017;13:e185-e192 published online January 2017 published online e-edition June 2017

Published in Volume 13 Number 2, June 2017

Clinical and angiographic predictors of haemodynamically significant angiographic lesions: development and validation of a risk score to predict positive fractional flow reserve

EuroIntervention 2017;12:e2228-e2235 published online February 2017 published online e-edition April 2017

Published in Volume 12 Number 18, April 2017

Clinical events beyond one year after an acute coronary syndrome: insights from the RECLOSE 2-ACS study

EuroIntervention 2017;12:2018-2024

Published in Volume 12 Number 16, March 2017

The long-term effect of transradial coronary catheterisation on upper limb function

EuroIntervention 2017;12:1766-1772

Published in Volume 12 Number 14, February 2017

Clinical outcomes of a real-world cohort following bioresorbable vascular scaffold implantation utilising an optimised implantation strategy

EuroIntervention 2017;12:1730-1737 published online October 2016

Published in Volume 12 Number 14, February 2017

Angiographic outcomes of Orsiro biodegradable polymer sirolimus-eluting stents and Resolute Integrity durable polymer zotarolimus-eluting stents: results of the ORIENT trial

EuroIntervention 2017;12:1623-1631

Published in Volume 12 Number 13, January 2017

The SYNERGY II Everolimus elutiNg stent In patients Older than 75 years undergoing coronary Revascularisation associated with a short dual antiplatelet therapy (SENIOR) trial: rationale and design of a large-scale randomised multicentre study

EuroIntervention 2017;12:1614-1622 published online ahead of print December 2015

Published in Volume 12 Number 13, January 2017

Comparison of clinical outcomes after multivessel versus single-vessel stenting with the zotarolimus-eluting stent in the RESOLUTE Global Clinical Trial Program

EuroIntervention 2017;12:1605-1613 published online October 2016

Published in Volume 12 Number 13, January 2017

Twelve-month results of a prospective, multicentre trial to assess the everolimus-eluting coronary stent system (PROMUS Element): the PLATINUM PLUS all-comers randomised trial

EuroIntervention 2017;12:1595-1604 published online November 2016

Published in Volume 12 Number 13, January 2017

Long-term outcomes after Resolute zotarolimus-eluting stent implantation in patients with ST-segment elevation acute myocardial infarction: insights from the RESOLUTE All Comers Trial and the RESOLUTE Global Clinical Trial Program

EuroIntervention 2016;12:1207-1214

Published in Volume 12 Number 10, November 2016

Variability in the measurement of minimum fibrous cap thickness and reproducibility of fibroatheroma classification by optical coherence tomography using manual versus semi-automatic assessment

EuroIntervention 2016;12:e987-e997 published online e-edition October 2016

Published in Volume 12 Number 8, October 2016

A computational atlas of normal coronary artery anatomy

EuroIntervention 2016;12:845-854

Published in Volume 12 Number 7, September 2016

Angiographic complexity of coronary artery disease according to SYNTAX score and clinical outcomes after revascularisation with newer-generation drug-eluting stents: a substudy of the BIOSCIENCE trial

EuroIntervention 2016;12:e695-e604 published online e-edition August 2016

Published in Volume 12 Number 5, August 2016

Two-year clinical outcomes of Absorb bioresorbable vascular scaffold implantation in complex coronary artery disease patients stratified by SYNTAX score and ABSORB II study enrolment criteria

EuroIntervention 2016;12:e557-e565 published online e-edition August 2016

Published in Volume 12 Number 5, August 2016

Early and midterm outcomes of bioresorbable vascular scaffolds for ostial coronary lesions: insights from the GHOST-EU registry

EuroIntervention 2016;12:e550-e556 published online ahead of print September 2015 published online e-edition August 2016

Published in Volume 12 Number 5, August 2016

Incidence and predictors of unplanned non-target lesion revascularisation up to three years after drug-eluting stent implantation: insights from a pooled analysis of the RESOLUTE Global Clinical Trial Program

EuroIntervention 2016;12:465-472 published online ahead of print July 2015

Published in Volume 12 Number 4, July 2016

Coronary angiography-related myocardial injury as detected by high-sensitivity cardiac troponin T assay

EuroIntervention 2016;12:337-344

Published in Volume 12 Number 3, June 2016

Outcome after percutaneous coronary intervention for different indications: long-term results from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)

EuroIntervention 2016;12:303-311 published online ahead of print October 2015

Published in Volume 12 Number 3, June 2016

Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease

EuroIntervention 2016;12:e224-e234 published online e-edition June 2016

Published in Volume 12 Number 2, June 2016

Impact of gender difference in hospital outcomes following percutaneous coronary intervention. Results of the Belgian Working Group on Interventional Cardiology (BWGIC) registry

EuroIntervention 2016;12:e216-e223 published online ahead of print December 2014 published online e-article June 2016

Published in Volume 12 Number 2, June 2016

Safety and performance of the DRug-Eluting Absorbable Metal Scaffold (DREAMS) in patients with de novo coronary lesions: 3-year results of the prospective, multicentre, first-in-man BIOSOLVE-I trial

EuroIntervention 2016;12:e160-e166 published online e-edition June 2016

Published in Volume 12 Number 2, June 2016

Effects of baseline and early acquired thrombocytopaenia on long-term mortality in patients undergoing percutaneous coronary intervention with bivalirudin

EuroIntervention 2016;11:e1627-e1638 published online e-edition April 2016

Published in Volume 11 Number 14, April 2016

The vulnerable artery: early and rapid deposition of lipid in coronary arteries is associated with subsequent development of thin-cap fibroatheromas

EuroIntervention 2016;11:e1612-e1618 published online e-edition April 2016

Published in Volume 11 Number 14, April 2016

First-in-man evaluation of the novel balloon delivery system STENTYS Xposition S for the self-apposing coronary artery stent: impact on longitudinal geographic miss during stenting

EuroIntervention 2016;11:1341-1345 published online ahead of print May 2015

Published in Volume 11 Number 12, March 2016

Real-world experience with a novel biodegradable polymer sirolimus-eluting stent: twelve-month results of the BIOFLOW-III registry

EuroIntervention 2016;11:1106-1110 published online ahead of print March 2015

Published in Volume 11 Number 10, February 2016

Paclitaxel-coated balloon catheter compared with drug-eluting stent for drug-eluting stent restenosis in routine clinical practice

EuroIntervention 2016;11:1098-1105 published online ahead of print February 2015

Published in Volume 11 Number 10, February 2016

Permanent and biodegradable polymer coatings in the absence of antiproliferative drugs in a porcine model of coronary artery stenting

EuroIntervention 2016;11:1020-1026 published online ahead of print October 2014

Published in Volume 11 Number 9, January 2016

Treatment of coronary bifurcation lesions with the Absorb bioresorbable vascular scaffold in combination with the Tryton dedicated coronary bifurcation stent: evaluation using two- and three-dimensional optical coherence tomography

EuroIntervention 2015;11:877-884 published online ahead of print August 2014

Published in Volume 11 Number 8, December 2015

Impact of side branch stenting on five-year long-term clinical outcome with the bifurcation-dedicated Axxess Biolimus A9-eluting stent system

EuroIntervention 2015;11:860-867

Published in Volume 11 Number 8, December 2015

Cystatin C and risk of mortality among patients undergoing percutaneous coronary intervention

EuroIntervention 2015;11:757-764 published online ahead of print August 2014

Published in Volume 11 Number 7, November 2015

Clinical impact of coronary protection during transcatheter aortic valve implantation: first reported series of patients

EuroIntervention 2015;11:572-581

Published in Volume 11 Number 5, September 2015

A comparison of multivessel and culprit vessel percutaneous coronary intervention in non-ST-segment elevation acute coronary syndrome patients with multivessel disease: a meta-analysis

EuroIntervention 2015;11:525-532

Published in Volume 11 Number 5, September 2015

Inter-hospital transfer for primary angioplasty: delays are often due to diagnostic uncertainty rather than systems failure and universal time metrics may not be appropriate

EuroIntervention 2015;11:511-517 published online ahead of print Avril 2014

Published in Volume 11 Number 5, September 2015

The effect of coronary artery disease defined by quantitative coronary angiography and SYNTAX score upon outcome after transcatheter aortic valve implantation (TAVI) using the Edwards bioprosthesis

EuroIntervention 2015;11:450-455 published online ahead of print May 2014

Published in Volume 11 Number 4, August 2015

Long-term outcomes of angiographically confirmed coronary stent thrombosis: results from a multicentre California registry

EuroIntervention 2015;11:188-195

Published in Volume 11 Number 2, June 2015

Beyond the early stages: insights from the ASSURE registry on bioresorbable vascular scaffolds

EuroIntervention 2015;11:149-156 published online ahead of print December 2014

Published in Volume 11 Number 2, June 2015

Impact of post-dilation on the acute and one-year clinical outcomes of a large cohort of patients treated solely with the Absorb Bioresorbable Vascular Scaffold

EuroIntervention 2015;11:141-148 published online ahead of print May 2015

Published in Volume 11 Number 2, June 2015

Pathological aspects of bioresorbable stent implantation

EuroIntervention 2015;11:V159-V165

Published in Volume 11 Supplement V, May 2015

Which technique for double stenting in unprotected left main bifurcation coronary lesions?

EuroIntervention 2015;11:V125-V128

Published in Volume 11 Supplement V, May 2015

When is a two-stent technique needed and which technique should then be used for bifurcation coronary lesions?

EuroIntervention 2015;11:V96-V98

Published in Volume 11 Supplement V, May 2015

Five-year outcomes of staged percutaneous coronary intervention in the SYNTAX study

EuroIntervention 2015;10:1402-1408

Published in Volume 10 Number 12, April 2015

The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled

EuroIntervention 2015;10:1396-1401 published online ahead of print April 2014

Published in Volume 10 Number 12, April 2015

Study of Patient Information after percutaneous Coronary Intervention (SPICI): should prevention programmes become more effective?

EuroIntervention 2015;10:e1-e7 published online e-article January 2014

Published in Volume 10 Number 11, March 2015

Five-year results of a randomised comparison of titanium-nitride-oxide-coated stents with zotarolimus-eluting stents for coronary revascularisation

EuroIntervention 2015;10:1284-1287 published online ahead of print January 2015

Published in Volume 10 Number 11, March 2015

Feasibility and early safety of hybrid coronary revascularisation combining off-pump coronary surgery through J-hemisternotomy with percutaneous coronary intervention

EuroIntervention 2015;10:e1-e6 published online ahead of print October 2013

Published in Volume 10 Number 10, February 2015

High-bolus dose tirofiban compared with abciximab in primary percutaneous coronary intervention: a propensity score-matched outcome study

EuroIntervention 2015;10:1187-1194 published online ahead of print May 2014

Published in Volume 10 Number 10, February 2015

Absorb everolimus-eluting bioresorbable scaffolds in coronary bifurcations: a bench study of deployment, side branch dilatation and post-dilatation strategies

EuroIntervention 2015;10:1169-1177published online ahead of print May 2014

Published in Volume 10 Number 10, February 2015

Initial experience and clinical evaluation of the Absorb bioresorbable vascular scaffold (BVS) in real-world practice: the AMC Single Centre Real World PCI Registry

EuroIntervention 2015;10:1160-1168 published online ahead of print August 2014

Published in Volume 10 Number 10, February 2015

Resolute zotarolimus-eluting coronary stent implantation in Asian patients with multivessel disease and long lesions: clinical outcomes in RESOLUTE Asia

AsiaIntervention 2015;1:18-25

Published in Asiaintervention Volume 1 Issue 1, January 2015

2014 ESC/EACTS Guidelines on myocardial revascularization

EuroIntervention 2015;10:1024-1094  published online ahead of print September 2014

Published in Volume 10 Number 9, January 2015

Different serial changes in the neointimal condition of sirolimus-eluting stents and paclitaxel-eluting stents: an optical coherence tomographic study

EuroIntervention 2014;10:924-933 published online ahead of print February 2014

Published in Volume 10 Number 8, December 2014

Effects of polyunsaturated fatty acids on periprocedural myocardial infarction after elective percutaneous coronary intervention

EuroIntervention 2014;10:792-798

Published in Volume 10 Number 7, November 2014

Assessment of the relation between initial culprit vessel patency in acute ST-elevation myocardial infarction and endothelial function

EuroIntervention 2014;10:784-791

Published in Volume 10 Number 7, November 2014

Thrombus capture by withdrawal of an open filter device: a useful treatment for large non-occlusive coronary thrombus

EuroIntervention 2014;10:689-693

Published in Volume 10 Number 6, October 2014

Coronary artery disease in patients undergoing TAVI - why not to treat

EuroIntervention 2014;10:U76-U83

Published in Volume 10 Supplement U, September 2014

Coronary artery disease in patients undergoing TAVI: why, what, when and how to treat

EuroIntervention 2014;10:U69-U75

Published in Volume 10 Supplement U, September 2014

Coronary artery treatment with paclitaxel-coated balloon using a BTHC excipient: clinical results of the international real-world DELUX registry

EuroIntervention 2014;10:591-599 published online ahead of print December 2013

Published in Volume 10 Number 5, September 2014

First experience with the jailed pressure wire technique in the provisional side branch stenting of coronary bifurcation lesions

EuroIntervention 2014;10:570-573

Published in Volume 10 Number 5, September 2014

Stent for Life Initiative: leading example in building STEMI systems of care in emerging countries

EuroIntervention 2014;10-T87-T95

Published in Volume 10 Supplement T, August 2014

Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial

EuroIntervention 2014;10:204-211

Published in Volume 10 Number 2, June 2014

Impact of antithrombotic treatment on short-term outcomes after percutaneous coronary intervention for left main disease: a pooled analysis from REPLACE-2, ACUITY, and HORIZONS-AMI trials

EuroIntervention 2014;10:97-104 published online ahead of print September 2013

Published in Volume 10 Number 1, May 2014

Prognostic value of bleeding after percutaneous coronary intervention in patients with diabetes

EuroIntervention 2014;10:83-89 published online ahead of print April 2014

Published in Volume 10 Number 1, May 2014

Perioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and non-cardiac surgery: a consensus document from Italian cardiological, surgical and anaesthesiological societies

EuroIntervention 2014;10:38-46

Published in Volume 10 Number 1, May 2014

Randomised comparison of strut coverage between Nobori biolimus-eluting and sirolimus-eluting stents: an optical coherence tomography analysis

EuroIntervention 2014;9:1389-1397 published online ahead of print February 2014

Published in Volume 9 Number 12, April 2014

Dynamics of vessel wall changes following the implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months

EuroIntervention 2014;9:1271-1284 published online ahead of print December 2013

Published in Volume 9 Number 11, March 2014

Transcatheter treatment for refractory angina with the coronary sinus Reducer

EuroIntervention 2014;9:1158-1164

Published in Volume 9 Number 10, February 2014

Early outcome after implantation of Absorb bioresorbable drug-eluting scaffolds in patients with acute coronary syndromes

EuroIntervention 2014;9:1036-1041 published online ahead of print September 2013

Published in Volume 9 Number 9, January 2014

Comparison of paclitaxel-eluting vs. everolimus-eluting stents implanted simultaneously in different lesions of the same coronary artery: 12-month follow-up with optical coherence tomography

EuroIntervention 2013;9:952-958

Published in Volume 9 Number 8, December 2013

Optical coherence tomography-based evaluation of in-stent neoatherosclerosis in lesions with more than 50% neointimal cross-sectional area stenosis

EuroIntervention 2013;9:945-951

Published in Volume 9 Number 8, December 2013

Microcatheter-facilitated reverse wire technique for side branch wiring in bifurcated vessels: an in vitro evaluation

EuroIntervention 2013;9:870-877

Published in Volume 9 Number 7, November 2013

Clinical outcomes after intravascular ultrasound and fractional flow reserve assessment of intermediate coronary lesions. Propensity score matching of large cohorts from two institutions with a differential approach

EuroIntervention 2013;9:824-830 published online ahead of print May 2013

Published in Volume 9 Number 7, November 2013

Optimal treatment of recurrent restenosis lesions after drug-eluting stent implantation for in-stent restenosis lesions

EuroIntervention 2013;9:788-796

Published in Volume 9 Number 7, November 2013

First-in-human experience using the Volcano VIBE-RX vascular imaging balloon catheter system (Volcano IVUS-guided Balloon Evaluation - New Zealand: VIBE-NZ Study)

EuroIntervention 2013;9:594-600 published online ahead of print January 2013

Published in Volume 9 Number 5, September 2013

Three-year clinical results of the Axxess Biolimus A9 eluting bifurcation stent system: the DIVERGE study

EuroIntervention 2013;9:573-581

Published in Volume 9 Number 5, September 2013

Severe aortic stenosis and coronary artery disease

EuroIntervention 2013;9:S63-S68

Published in Volume 9 Supplement S, September 2013

First-in-human evaluation of the novel BioMime sirolimus-eluting coronary stent with bioabsorbable polymer for the treatment of single de novo lesions located in native coronary vessels - results from the meriT-1 trial

EuroIntervention 2013;9:493-500

Published in Volume 9 Number 4, August 2013

Two-year outcomes of everolimus vs. paclitaxel-eluting stent for the treatment of unprotected left main lesions: a propensity score matching comparison of patients included in the French Left Main Taxus (FLM Taxus) and the LEft MAin Xience (LEMAX) registries

EuroIntervention 2013;9:452-462

Published in Volume 9 Number 4, August 2013

Three-year outcome after percutaneous coronary intervention and coronary artery bypass grafting in patients with triple-vessel coronary artery disease: observations from the CREDO-Kyoto PCI/CABG registry cohort-2

EuroIntervention 2013;9:437-445

Published in Volume 9 Number 4, August 2013

Detailed analysis of polymer response to delivery balloon expansion of drug-eluting stents versus bare metal stents

EuroIntervention 2013;9:389-397

Published in Volume 9 Number 3, July 2013

Six-month and one-year clinical outcomes after placement of a dedicated coronary bifurcation stent: a patient-level pooled analysis of eight registry studies

EuroIntervention 2013;9:195-203

Published in Volume 9 Number 2, June 2013

Clinical and angiographic outcomes following first-in-man implantation of a novel thin-strut low-profile fixed-wire stent: the Svelte Coronary Stent Integrated Delivery System first-in-man trial

EuroIntervention 2013;9:125-134

Published in Volume 9 Number 1, May 2013

Impact of ad hoc percutaneous coronary intervention with drug-eluting stents in angina patients

EuroIntervention 2013;9:110-117

Published in Volume 9 Number 1, May 2013

First-in-human evaluation of a sirolimus-eluting coronary stent on an integrated delivery system: the DIRECT study

EuroIntervention 2013;9:46-53

Published in Volume 9 Number 1, May 2013

Direct comparison between coronary computed tomography and invasive angiography for calculation of SYNTAX score

EuroIntervention 2013;8:1428-1434

Published in Volume 8 Number 12, April 2013

Comparison of intravenous adenosine and intravenous regadenoson for the measurement of pressure-derived coronary fractional flow reserve

EuroIntervention 2013;8:1166-1171 published online ahead of print November 2012

Published in Volume 8 Number 10, February 2013

Impact of atrial fibrillation on clinical outcomes among patients with coronary artery disease undergoing revascularisation with drug-eluting stents

EuroIntervention 2013;8:1061-1071

Published in Volume 8 Number 9, January 2013

A randomised study of dabigatran in elective percutaneous coronary intervention in stable coronary artery disease patients

EuroIntervention 2013;8:1052-1060 published online ahead of print November 2012

Published in Volume 8 Number 9, January 2013

Five-year long-term clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery disease: the SPIRIT II trial

EuroIntervention 2013;8:1047-1051

Published in Volume 8 Number 9, January 2013

First-in-man evaluation of the MOMO cobalt-chromium carbon-coated stent

EuroIntervention 2013;8:1012-1018

Published in Volume 8 Number 9, January 2013

Clinical and angiographic experience with a third-generation drug-eluting Orsiro stent in the treatment of single de novo coronary artery lesions (BIOFLOW-I): a prospective, first-in-man study

EuroIntervention 2013;8:1006-1011

Published in Volume 8 Number 9, January 2013

Unprotected left main stenting in the real world: five-year outcomes of the French Left Main Taxus registry

EuroIntervention 2012;8:970-981

Published in Volume 8 Number 8, December 2012

Short- and long-term outcomes in octogenarians undergoing percutaneous coronary intervention with stenting

EuroIntervention 2012;8:920-928

Published in Volume 8 Number 8, December 2012

Real-world use of the second-generation cobalt-chromium sirolimus-eluting stents: 12-month results from the prospective multicentre FOCUS registry

EuroIntervention 2012;8:896-903

Published in Volume 8 Number 8, December 2012

Angiography alone versus angiography plus optical coherence tomography to guide decision-making during percutaneous coronary intervention: the Centro per la Lotta contro l’Infarto-Optimisation of Percutaneous Coronary Intervention (CLI-OPCI) study

EuroIntervention 2012;8:823-829

Published in Volume 8 Number 7, November 2012

Vascular responses to a biodegradable polymer (polylactic acid) based Biolimus A9-eluting stent in porcine models

EuroIntervention 2012;8:743-751

Published in Volume 8 Number 6, October 2012

Comparison of vascular response to the everolimus-eluting stent versus the paclitaxel-eluting stent: intravascular ultrasound results from the SPIRIT III trial

EuroIntervention 2012;8:724-731

Published in Volume 8 Number 6, October 2012

Comparison of eligible non-enrolled patients and the randomised TWENTE trial population treated with Resolute and XIENCE V drug-eluting stents

EuroIntervention 2012;8:664-671

Published in Volume 8 Number 6, October 2012

The transradial versus the transfemoral approach for primary percutaneous coronary intervention in patients with acute myocardial infarction: a systematic review and meta-analysis

EuroIntervention 2012;8:501-510 published online ahead of print May 2012

Published in Volume 8 Number 4, August 2012

Paclitaxel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study

EuroIntervention 2012;8:450-455

Published in Volume 8 Number 4, August 2012

Simplifying clinical risk prediction for percutaneous coronary intervention of bifurcation lesions: the case for the ACEF (age, creatinine, ejection fraction) score

EuroIntervention 2012;8:359-367 published online ahead of print May 2012

Published in Volume 8 Number 3, July 2012

Usefulness and safety of the GuideLiner catheter to enhance intubation and support of guide catheters: insights from the Twente GuideLiner registry

EuroIntervention 2012;8:336-344

Published in Volume 8 Number 3, July 2012

SPIRIT Women, evaluation of the safety and efficacy of the XIENCE V everolimus-eluting stent system in female patients: referral time for coronary intervention and 2-year clinical outcomes

EuroIntervention 2012;8:325-335

Published in Volume 8 Number 3, July 2012

Dedicated paclitaxel-eluting bifurcation stent BiOSS® (bifurcation optimisation stent system): 12-month results from a prospective registry of consecutive all-comers population

EuroIntervention 2012;8:316-324

Published in Volume 8 Number 3, July 2012

Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-study

EuroIntervention 2012;8:214-224

Published in Volume 8 Number 2, June 2012

Sealing pseudo-aneurysms of the femoral artery with saline injection: a new technique

EuroIntervention 2012;7:1206-1209

Published in Volume 7 Number 10, February 2012

Clinical outcomes based on completeness of revascularisation in patients undergoing percutaneous coronary intervention: a meta-analysis of multivessel coronary artery disease studies

EuroIntervention 2012;7:1095-1102 publish online ahead of print September 2011

Published in Volume 7 Number 9, January 2012

Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial

EuroIntervention 2012;7:1060-1061 publish onlinea ahead of print September 2011

Published in Volume 7 Number 9, January 2012

A comparative analysis of major clinical outcomes with drug-eluting stents versus bare metal stents in male versus female patients

EuroIntervention 2012;7:1051-1059

Published in Volume 7 Number 9, January 2012

Outcomes in patients undergoing multivessel percutaneous coronary intervention using sirolimus-eluting stents: a report from the e-SELECT registry

EuroIntervention 2011;7:962-968

Published in Volume 7 Number 8, December 2011

Cardiovascular risk profile of patients included in stent trials; a pooled analysis of individual patient data from randomised clinical trials: insights from 33 prospective stent trials in Europe

EuroIntervention 2011;7:859-871

Published in Volume 7 Number 7, November 2011

Three-year outcome of sirolimus-eluting stent implantation in coronary bifurcation lesions: the provisional side branch stenting approach versus the elective two-stent approach

EuroIntervention 2011;7:588-596

Published in Volume 7 Number 5, September 2011

Six-month clinical and angiographic results of the STENTYS® self-apposing stent in bifurcation lesions

EuroIntervention 2011;7:580-587

Published in Volume 7 Number 5, September 2011

Impact of coronary artery disease on indications for transcatheter aortic valve implantation and on procedural outcomes

EuroIntervention 2011;7:549-555

Published in Volume 7 Number 5, September 2011

Impact of coronary artery disease and percutaneous coronary intervention on outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation

EuroIntervention 2011;7:541-548

Published in Volume 7 Number 5, September 2011

Cardio-respiratory exercise testing early after the use of the Angio-Seal system for arterial puncture site closure after coronary angioplasty

EuroIntervention 2011;7:242-247

Published in Volume 7 Number 2, June 2011

High shear stress induces a strain increase in human coronary plaques over a 6-month period

EuroIntervention 2011;7:121-127

Published in Volume 7 Number 1, May 2011

PLATINUM QCA: a prospective, multicentre study assessing clinical, angiographic, and intravascular ultrasound outcomes with the novel platinum chromium thin-strut PROMUS Element everolimus-eluting stent in de novo coronary stenoses

EuroIntervention 2011;7:84-90

Published in Volume 7 Number 1, May 2011

Predictors of death or myocardial infarction, ischaemic-driven revascularisation, and major adverse cardiovascular events following everolimus-eluting or paclitaxel-eluting stent deployment: pooled analysis from the SPIRIT II, III, IV and COMPARE trials

EuroIntervention 2011;7:74-83

Published in Volume 7 Number 1, May 2011

Drug-eluting balloons: future potential indications and applications

EuroIntervention 2011;7:K112-K118

Published in Volume 7 Supplement K, May 2011

Antiplatelet therapy in the era of percutaneous coronary intervention with drug-eluting balloons

EuroIntervention 2011;7:K106-K111

Published in Volume 7 Supplement K, May 2011

Treatment of bifurcation lesions with a drug-eluting balloon: the PEPCAD V (Paclitaxel Eluting PTCA Balloon in Coronary Artery Disease) trial

EuroIntervention 2011;7:K61-K65

Published in Volume 7 Supplement K, May 2011

A novel method for the measurement of proximal fibrous cap puncture force in chronic total occlusions: the effect of increasing age

EuroIntervention 2011;6:997-1002

Published in Volume 6 Number 8, March 2011

Magnetic navigation system assisted stenting of coronary bifurcation lesions

EuroIntervention 2011;6:970-976

Published in Volume 6 Number 8, March 2011

The impact of an eccentric intravascular ImageWire during coronary optical coherence tomography imaging

EuroIntervention 2011;6:963-969

Published in Volume 6 Number 8, March 2011

Influence of age on the clinical outcomes of coronary revascularisation for the treatment of patients with multivessel de novo coronary artery lesions: sirolimus-eluting stent vs. coronary artery bypass surgery and bare metal stent, insight from the multicentre randomised Arterial Revascularisation Therapy Study Part I (ARTS-I) and Part II (ARTS-II)

EuroIntervention 2010;6:838-845 - DOI10.4244/EIJV6I6A144

Published in Volume 6 Number 7, February 2011

A randomised, double-blind, placebo-controlled, multicentre study of the safety and efficacy of BIOBYPASS (AdGVVEGF121.10NH) gene therapy in patients with refractory advanced coronary artery disease: the NOVA trial

EuroIntervention 2010;6:813-818 - DOI10.4244/EIJV6I6A140

Published in Volume 6 Number 7, February 2011

Assessment of the coronary calcification by optical coherence tomography

EuroIntervention 2011;6:768-772 published online ahead of print November 2010

Published in Volume 6 Number 6, January 2011

Late outcome after intracoronary beta radiation brachytherapy: a matched-propensity controlled ten-year follow-up study

EuroIntervention 2011;6:695-702

Published in Volume 6 Number 6, January 2011

Sirolimus-eluting stent implantation versus beta-irradiation for the treatment of in-stent restenotic lesions: clinical and ultrasound results from a randomised trial

EuroIntervention 2011;6:687-694

Published in Volume 6 Number 6, January 2011

Percutaneous coronary intervention in the elderly: results from the Thai National Percutaneous Coronary Intervention Registry (TPCIR)

EuroIntervention 2010;6:611-615

Published in Volume 6 Number 5, November 2010

Long-term follow-up of the randomised controlled trial to evaluate the safety and efficacy of the zotarolimus-eluting driver coronary stent in de novo native coronary artery lesions: five year outcomes in the ENDEAVOR II study

EuroIntervention 2010;6:562-567

Published in Volume 6 Number 5, November 2010

Three-year results of clinical follow-up after a bioresorbable everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB trial

EuroIntervention 2010;6:447-453 published online ahead of print June 2010

Published in Volume 6 Number 4, September 2010

Reproducibility of coronary Fourier domain optical coherence tomography: quantitative analysis of in vivo stented coronary arteries using three different software packages

EuroIntervention 2010;6:371-379

Published in Volume 6 Number 3, August 2010

Clinical outcome after endovascular, surgical or hybrid revascularisation in patients with combined carotid and coronary artery disease: the Finalised Research In ENDovascular Strategies Study Group (FRIENDS)

EuroIntervention 2010;6:328-335

Published in Volume 6 Number 3, August 2010

Single-photon emission computed tomography for assessment of myocardial viability

EuroIntervention Supplement (2010) Vol. 6 (Supplement G) G115-G122

Published in Volume 6 Supplement G, May 2010

Function and anatomy: SPECT-MPI and MSCT coronary angiography

EuroIntervention Supplement (2010) Vol. 6 (Supplement G) G94-G100

Published in Volume 6 Supplement G, May 2010

Micro-computed tomographic assessment following extremely oversized partial postdilatation of drug-eluting stents

EuroIntervention 2010;6:141-148 - DOI10.4244/EIJV6I1A21

Published in Volume 6 Number 1, May 2010

Incidence, predictors and prognostic importance of bleeding after primary PCI for ST-elevation myocardial infarction

EuroIntervention 2010;6:106-111

Published in Volume 6 Number 1, May 2010

A European multicentre, randomised study of the MAR-Tyn cobalt chromium tin-coated stent in patients with de novo coronary artery lesions: study design and protocol

EuroIntervention 2010;5:976-980

Published in Volume 5 Number 8, April 2010

Paclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes

EuroIntervention 2010;5:898-905 - DOI10.4244/EIJV5I8A153

Published in Volume 5 Number 8, April 2010

Pulse wave analysis during instructed breathing as an indicator of significant coronary artery disease

EuroIntervention 2010;5:847-852 - DOI10.4244/EIJV5I7A142

Published in Volume 5 Number 7, February 2010

Sex-related differences in patients undergoing percutaneous unprotected left main stenting

EuroIntervention 2010;5:795-800

Published in Volume 5 Number 7, February 2010

A pooled gender based analysis comparing the XIENCE V® everolimus-eluting stent and the TAXUS paclitaxel-eluting stent in male and female patients with coronary artery disease, results of the SPIRIT II and SPIRIT III studies: two-year analysis

EuroIntervention 2010;5:788-794

Published in Volume 5 Number 7, February 2010

Long-term clinical outcomes with the next-generation Resolute Stent System: a report of the two-year follow-up from the RESOLUTE clinical trial

EuroIntervention 2010;5:692-697

Published in Volume 5 Number 6, January 2010

Design principles and performance of bioresorbable polymeric vascular scaffolds

EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F15-F22

Published in Volume 5 Supplement F, December 2009

Compositional volumetry of non-calcified coronary plaques by multislice computed tomography: an ex vivo feasibility study

EuroIntervention 2009;5:558-564

Published in Volume 5 Number 5, November 2009

Scanning electron microscopic assessment of the biodegradable coating on expanded biolimus-eluting stents

EuroIntervention 2009;5:505-510 - DOI10.4244/EIJV5I4A80

Published in Volume 5 Number 4, September 2009

Angiographic and intravascular ultrasound findings following implantation of the Endeavor™ zotarolimus-eluting stents in patients from the real-world clinical practice

EuroIntervention 2009;5:355-362

Published in Volume 5 Number 3, August 2009

Nationwide trends in the utilisation of percutaneous coronary intervention (PCI) in the United States of America based on gender and ethnicities

EuroIntervention 2009;5:343-348

Published in Volume 5 Number 3, August 2009

Impact of dye injection on intracoronary pressure

EuroIntervention 2009;5:272-276

Published in Volume 5 Number 2, June 2009

Coating irregularities of durable polymer-based drug-eluting stents as assessed by scanning electron microscopy

EuroIntervention 2009;5:157-165

Published in Volume 5 Number 1, May 2009

Porcine models of coronary atherosclerosis and vulnerable plaque for imaging and interventional research

EuroIntervention 2009;5:140-148

Published in Volume 5 Number 1, May 2009

PRO-Kinetic: results from an “all-comers” single centre clinical experience

EuroIntervention 2009;5:109-114 - DOI10.4244/EIJV5I1A17

Published in Volume 5 Number 1, May 2009

Long-term clinical and angiographic outcomes of the sleeve technique on non-left-main coronary bifurcation lesions

EuroIntervention 2009;5:104-108 - DOI10.4244/EIJV5I1A16

Published in Volume 5 Number 1, May 2009

Novel method for real-time hybrid cardiac CT and coronary angiography image registration: visualising beyond luminology, proof-of-concept

EuroInterv.2009;4 648-653

Published in Volume 4 Number 5, March 2009

TAXUS VI final 5-year results: a multicentre, randomised trial comparing polymer-based moderate-release paclitaxel-eluting stent with a bare metal stent for treatment of long, complex coronary artery lesions

EuroInterv.2009;4 572-577

Published in Volume 4 Number 5, March 2009

Clinical investigation into the observation that silicon carbide coating on cobalt chromium stents leads to early differentiating functional endothelial layer, increased safety and DES-like recurrent stenosis rates: results of the PRO-Heal Registry (PRO-Kinetic enhancing rapid in-stent endothelialisation)

EuroInterv.2009;4:502-508

Published in Volume 4 Number 4, January 2009

Quantitative multi-modality imaging analysis of a bioabsorbable poly-L-lactic acid stent design in the acute phase: a comparison between 2- and 3D-QCA, QCU and QMSCT-CA

EuroIntervention 2008;4:285-291 - DOI10.4244/EIJV4I2A49

Published in Volume 4 Number 2, August 2008

Biodegradable-polymer-based, sirolimus-eluting Supralimus® stent: 6-month angiographic and 30-month clinical follow-up results from the Series I prospective study

EuroIntervention 2008;4:59-63 - DOI10.4244/EIJV4I1A11

Published in Volume 4 Number 1, May 2008

Percutaneous coronary stenting in patients with left ventricular systolic dysfunction: a systematic review and meta-analysis

EuroInterv.2007;3:409-415

Published in Volume 3 Number 3, November 2007

Making sense of the recent meta-analytical confusion concerning the safety of drug-eluting stents

EuroIntervention 2007;3:381-385 - DOI10.4244/EIJV3I3A68

Published in Volume 3 Number 3, November 2007

Short- and long-term outcomes of percutaneous coronary interventions in patients with severe left ventricular dysfunction

EuroIntervention 2007;3:359-364 - DOI10.4244/EIJV3I3A65

Published in Volume 3 Number 3, November 2007

Appraising the effectiveness and safety of paclitaxel-eluting stents in over 1,000 very high-risk patients: overall results of the Taxus in Real-life Usage Evaluation (TRUE) Registry

EuroInterv.2007;3:333-339

Published in Volume 3 Number 3, November 2007

Persistent angina in "no option" patients with advanced coronary artery disease

EuroIntervention Supplements (2007) 2 (Supplement B) B66-B70

Published in Volume 2 Supplement B, April 2007

The European cobalt STent with Antiproliferative for Restenosis trial (EuroSTAR): 12 month results

EuroInterv.2007;3:82-88

Published in Volume 3 Number 1, May 2007

Tryton I, First-In-Man (FIM) Study: acute and 30 day outcome.

EuroIntervention 2007;3:54-59 - DOI10.4244/EIJV3I1A09

Published in Volume 3 Number 1, May 2007

The next-generation Endeavor™ Resolute™ stent: 4-month clinical and angiographic results from the Endeavor™ Resolute™ first-in-man trial

EuroIntervention 2007;3:50-53 - DOI10.4244/EIJV3I1A08

Published in Volume 3 Number 1, May 2007

Coronary perforations

EuroInterv.2006;2:363-370

Published in Volume 2 Number 3, November 2006

Sirolimus-Eluting Stents vs Bare Metal Stents for the treatment of unprotected left main coronary artery stenosis

EuroIntervention 2006;2:356-362 - DOI10.4244/EIJV2I3A63

Published in Volume 2 Number 3, November 2006

Human myocardium preconditioning during successive balloon inflations: irrelevant influence of both collateral recruitment and clinical pre-intervention interference

EuroInterv.2006;2:345-350

Published in Volume 2 Number 3, November 2006

Biodegradable-polymer-based, paclitaxel-eluting Infinnium™ stent: 9-Month clinical and angiographic follow-up results from the SIMPLE II prospective multi-centre registry study

EuroIntervention 2006;2:310-317 - DOI10.4244/EIJV2I3A56

Published in Volume 2 Number 3, November 2006

Principles of a self contained catheterisation laboratory based intravascular magnetic resonance system

EuroInterv.2006;2:262-264

Published in Volume 2 Number 2, August 2006

Low incidence of cardiac biomarker elevation following PCI of chronic total coronary occlusions

EuroIntervention 2006;2:231-237 - DOI10.4244/EIJV2I2A39

Published in Volume 2 Number 2, August 2006

Direct stenting of de novo coronary stenoses with tacrolimus-eluting versus carbon-coated carbostents. The randomized JUPITER II trial

EuroIntervention 2006;2:45-52 - DOI10.4244/EIJV2I1A09

Published in Volume 2 Number 1, May 2006

Prospective non-randomized multi-center evaluation of the non-polymer based ACHIEVE™ Paclitaxel Eluting Coronary Stent System in treatment of lesions with high risk of revascularization due to restenosis: the DELIVER II study

EuroInterv.2006;1:385-390

Published in Volume 1 Number 4, February 2006

One-year results of a durable polymer everolimus-eluting stent in de novo coronary narrowings
(The SPIRIT FIRST Trial)

EuroInterv.2005;1:266-272

Published in Volume 1 Number 3, November 2005

Assessment of stent dimensions with a novel intracoronary balloon-based system: comparative study versus intravascular ultrasound and quantitative coronary angiography. The CAMUS - Coronary Angioplasty Metricath vs. UltraSound Trial

EuroIntervention 2005;1:244-251 - DOI10.4244/EIJV1I2A39

Published in Volume 1 Number 2, August 2005